Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 28, 2026
Why Is Intel Corporation (INTC) Stock Down -5.61% Today?

Why Is Intel Corporation (INTC) Stock Down -5.61% Today?

Key Takeaways

  • Intel shares fell 5.61% in Tuesday's session, extending a brutal multi-week sell-off that has erased more than a third of the stock's value from its June peak.
  • A broad semiconductor rout is the primary catalyst, triggered by escalating U.S.-China AI tensions and a plunge in Asian chip stocks that rippled through global markets.
  • Company-specific headwinds — including reports of delayed 18A process profitability, AMD surpassing Intel in data-center revenue, and concerns over mounting capital expenditures — are compounding the selling pressure.
  • The stock has now fallen roughly 38% from its 52-week high of $142.35 reached in late June, despite posting its strongest quarterly revenue growth in over 15 years just last week.
  • Traders are watching for stabilization in the Philadelphia Semiconductor Index, upcoming Big Tech earnings, and any fresh commentary on Intel's foundry customer pipeline.

Opening Summary

INTC — Intel Corporation, the American semiconductor giant and one of the world's largest chipmakers by revenue — tumbled 5.61% in Tuesday trading, with shares changing hands at $86.53 after closing the prior session at $91.67. The decline marks the latest leg in a punishing sell-off that has gripped the broader semiconductor sector, as investors grapple with rising geopolitical friction between the United States and China and mounting questions about whether runaway AI infrastructure spending can be sustained.

U.S.-China AI Tensions Trigger Broad Chip Sell-Off

The most immediate catalyst for Tuesday's drop was a sharp escalation in rhetoric between Washington and Beijing. China's commerce ministry accused the United States of "AI hegemonism" after U.S. officials signaled potential new investigations, sanctions, and trade restrictions related to the alleged theft of American AI technology. Beijing vowed to "take all necessary measures to firmly safeguard its legitimate rights and interests," raising fears of a tit-for-tat escalation that could disrupt semiconductor supply chains and restrict market access for U.S. chipmakers.

The geopolitical flare-up triggered a wave of selling across Asian markets first, where South Korea's Samsung Electronics and SKHY (SK Hynix) each plunged more than 13%. The Kospi index was paused for 20 minutes after dropping 8% and ultimately closed down 10.8%. Japan's Kioxia Holdings fell over 18%. The carnage then swept through U.S. pre-market and regular trading, hitting names across the semiconductor complex — NVDA, AMD, MU, and SNDK all traded sharply lower alongside Intel.

18A Yield Concerns and Competitive Pressures Add Fuel to the Fire

Beyond the macro headwinds, Intel is contending with its own set of company-specific challenges that have left the stock especially vulnerable to the sector-wide downdraft. Recent industry reports suggest that Intel's 18A manufacturing process — the cornerstone of its foundry turnaround strategy — may not reach profitable yield levels until late 2026 or even 2027, a timeline that falls short of what bullish investors had priced in. Every chip that comes off the line unusable represents wasted wafer cost, squeezing both revenue and margins at a time when the foundry business is still deeply unprofitable.

Compounding the narrative, AMD surpassed Intel in data-center revenue during the most recently reported quarter, generating $5.8 billion versus Intel's $5.1 billion. While Intel still ships roughly two-thirds of server CPU units, AMD continues to win the higher-priced chips, steadily eroding Intel's grip on what has historically been its most profitable market.

Post-Earnings Hangover Despite Blowout Results

The sell-off is particularly striking given that Intel delivered what CEO Lip-Bu Tan called its "strongest revenue growth in more than fifteen years" when it reported second-quarter results on July 23. Revenue of $16.1 billion grew 25% year-over-year and crushed consensus estimates by roughly $1.7 billion. Non-GAAP earnings per share of $0.42 nearly doubled the Street's $0.22 forecast. Data Center and AI revenue surged 59% to $6.3 billion. Third-quarter guidance also came in well above expectations.

Yet the stock's initial after-hours pop quickly faded, and Intel shares have now declined roughly 21% over the past week alone. The market's tepid response reflects a broader shift in sentiment: investors are no longer rewarding earnings beats unconditionally and are instead scrutinizing the escalating capital expenditure required to sustain AI-driven growth. Intel raised its 2026 capex guidance to over $20 billion and signaled that 2027 spending would be "significantly above" that level — a commitment that has raised concerns about free cash flow pressure and potential shareholder dilution.

Market Context and Trading Activity

Volume in INTC shares has been running significantly above average throughout the sell-off, with recent daily sessions regularly exceeding 130 million shares traded compared to typical volumes in the 60–80 million range earlier in the year. The Philadelphia Semiconductor Index has been in correction territory for weeks, and Tuesday's decline was broad-based rather than isolated to Intel, confirming that sector rotation and risk-off positioning are the dominant forces at play. Intel's moves have been highly correlated with peers, though the stock has underperformed due to the idiosyncratic concerns around foundry profitability and data-center market share.

What Comes Next for INTC

The immediate path forward for Intel depends heavily on two external forces: whether U.S.-China tensions escalate further or de-escalate, and whether upcoming earnings from Big Tech companies and memory chip makers reinforce or undermine confidence in AI infrastructure spending. On the company side, investors will be looking for concrete evidence that 18A yields are improving and that Intel is converting its foundry pipeline into signed customer agreements. The search for an anchor tenant at its Ohio fabrication facility — with SKHY (SK Hynix) reportedly among the candidates — remains a key milestone. Risks include a slower-than-anticipated node ramp, continued data-center share losses to AMD, and any signs that AI demand growth is decelerating.

Trending AI Robots

For traders seeking to navigate volatile market conditions with data-driven precision, Tickeron's Trending AI Robots page offers a curated selection of AI-powered trading bots. Tickeron hosts hundreds of automated trading bots covering thousands of tickers, but only the strongest performers under current market conditions — across diverse strategies, timeframes, and performance metrics — are featured in this dynamically updated section. Whether markets are rallying or selling off, these bots are designed to adapt and identify opportunities. Explore the Trending AI Robots to see which algorithms are leading the pack right now.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: INTC

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


INTC in upward trend: price may jump up because it broke its lower Bollinger Band on July 29, 2026

INTC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 30 cases where INTC's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where INTC's RSI Oscillator exited the oversold zone, of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for INTC just turned positive on August 04, 2026. Looking at past instances where INTC's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where INTC advanced for three days, in of 311 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Momentum Indicator moved below the 0 level on July 02, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on INTC as a result. In of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

INTC moved below its 50-day moving average on July 07, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for INTC crossed bearishly below the 50-day moving average on July 14, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INTC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for INTC entered a downward trend on August 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. INTC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.750) is normal, around the industry mean (16.094). INTC's P/E Ratio (904.167) is considerably higher than the industry average of (162.735). Projected Growth (PEG Ratio) (1.359) is also within normal values, averaging (1.904). Dividend Yield (0.004) settles around the average of (0.015) among similar stocks. P/S Ratio (8.584) is also within normal values, averaging (47.773).

Notable companies

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Broadcom Inc. (NASDAQ:AVGO), Taiwan Semiconductor Manufacturing Company Ltd (NYSE:TSM), Micron Technology (NASDAQ:MU), Advanced Micro Devices (NASDAQ:AMD), Intel Corp (NASDAQ:INTC), Texas Instruments (NASDAQ:TXN), Marvell Technology (NASDAQ:MRVL), Analog Devices (NASDAQ:ADI), QUALCOMM (NASDAQ:QCOM).

Industry description

The semiconductor industry manufacturers all chip-related products, including research and development. These chips are used in innumerable electronic devices, including computers, cell phones, smartphones, and GPSs. Intel Corporation, NVIDIA Corp., and Broadcomm are some of the prominent players in this industry. Semiconductor companies usually tend to do well during periods of healthy economic growth, thereby inducing further research and development in the industry – which in turn augurs well for productivity and growth in the economy. In the near future, demand for semiconductor products (and possibly innovation within the segment) should only expand further, with the proliferation of 5G, autonomous vehicles, IoT, and various AI-driven electronics set to herald a new, advanced chapter in the technology-driven world as we know it. With burgeoning prospects comes great competition. In 2015, SIA estimated that U.S. semiconductor industry ranks as the second most competitive U.S. industry out of 2882 U.S. industries designated manufacturers by the U.S. Census Bureau.

Market Cap

The average market capitalization across the Semiconductors Industry is 187.57B. The market cap for tickers in the group ranges from 13.43K to 5.31T. NVDA holds the highest valuation in this group at 5.31T. The lowest valued company is CYBL at 13.43K.

High and low price notable news

The average weekly price growth across all stocks in the Semiconductors Industry was 7%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was 43%. SITM experienced the highest price growth at 30%, while ON experienced the biggest fall at -6%.

Volume

The average weekly volume growth across all stocks in the Semiconductors Industry was -34%. For the same stocks of the Industry, the average monthly volume growth was -31% and the average quarterly volume growth was -62%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 60
P/E Growth Rating: 53
Price Growth Rating: 48
SMR Rating: 75
Profit Risk Rating: 73
Seasonality Score: -27 (-100 ... +100)
View a ticker or compare two or three
INTC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of computer components and related products

Industry Semiconductors

Profile
Details
Industry
Semiconductors
Address
2200 Mission College Boulevard
Phone
+1 408 765-8080
Employees
85100
Web
https://www.intel.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.